Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL. [electronic resource]
Producer: 20150424Description: 4050-9 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Positron-Emission Tomography -- methods
- Prednisone -- therapeutic use
- Prognosis
- Rituximab
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.